Kun Wang

13.7k citations
149 papers · 9.6k · 4 hit papers · h-index 45

Impact in

    • MicroRNA in disease regulation
    • Cancer-related molecular mechanisms research
    • Circular RNAs in diseases
    • Inflammasome and immune disorders
    • RNA modifications and cancer
    • RNA Research and Splicing
    • Extracellular vesicles in disease
    • Mitochondrial Function and Pathology

Papers in

    • Circular RNAs in diseases 53
    • RNA modifications and cancer 35
    • RNA Research and Splicing 11
    • RNA and protein synthesis mechanisms 9
    • Cancer-related gene regulation 8
    • MicroRNA in disease regulation 61
    • Cancer-related molecular mechanisms research 37

Kun Wang

142 papers receiving 9.5k citations

Kun Wang's Hit Papers

A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223 2016 · 746 citations
7460+5+10Years since publication50010001.5k2.0k

Peers

Kun Wang
Comparison fields: 5 of 140
  • Cancer Research 4.0k
  • Molecular Biology 7.3k
  • Nephrology 364
  • Immunology 1.0k
  • Cardiology and Cardiovascular Medicine 644
Replace Anton Jan van Zonneveld with:
Anton Jan van Zonneveld Netherlands
Eva van Rooij Netherlands
Cun‐Yu Wang United States
Zhen Chen China
Anton J.G. Horrevoets Netherlands
Min Xie United States
Alain Mauviel France
Bin Zhang China
Reinier A. Boon Germany
Raj Kishore United States
Kun Wang relative to Anton Jan van Zonneveld Netherlands Anton Jan van Zonneveld's profile →
Citations per field
00.5×3.0×
Anton Jan van Zonneveld · 1×
Citations per year

Countries citing papers authored by Kun Wang

Since Specialization
Citations

This map shows the geographic impact of Kun Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kun Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kun Wang more than expected).

Fields of papers citing papers by Kun Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kun Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kun Wang. The network helps show where Kun Wang may publish in the future.

Co-authors

The 25 scholars most cited alongside Kun Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kun Wang Line = papers co-authored together Kun Wang links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 149 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pore-forming activity and structural autoinhibition of the gasdermin family
Hit paper breakdown →
20162160
2
A circular RNA protects the heart from pathological hypertrophy and heart failure by targeting miR-223
Hit paper breakdown →
2016746
3
miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1
Hit paper breakdown →
2010511
4
The Long Noncoding RNA CHRF Regulates Cardiac Hypertrophy by Targeting miR-489
Hit paper breakdown →
2014466
5 2017286
6 2017277
7 2018218
8 2019176
9 2008169
10 2012167
11 2019157
12 2015156
13 2019143
14 2017136
15 2010134
16 2017112
17 2010110
18 2019104
19 2018100
20 201398

About Kun Wang

Kun Wang is a scholar working on Molecular Biology, Cancer Research, Pulmonary and Respiratory Medicine, Oncology and Immunology, having authored 149 papers that have together received 9.6k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (61 papers), Circular RNAs in diseases (53 papers), Cancer-related molecular mechanisms research (37 papers), RNA modifications and cancer (35 papers), RNA Research and Splicing (11 papers), Ferroptosis and cancer prognosis (9 papers), RNA and protein synthesis mechanisms (9 papers) and Cancer-related gene regulation (8 papers). The work is most often cited by research in Cancer Research (4.0k citations), Molecular Biology (7.3k citations), Nephrology (364 citations), Immunology (1.0k citations) and Cardiology and Cardiovascular Medicine (644 citations). Kun Wang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Peifeng Li, Bo Long, Wang Liu, Jianjin Shi, Hanzi Sun, Feng Shao, Qi Sun, Dacheng Wang, Jingjin Ding and Lu‐Yu Zhou. Their work appears in journals such as Cell Death Discovery, Molecular Therapy — Nucleic Acids, Journal of Cellular and Molecular Medicine, Cell Death and Differentiation and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact